Fate is as strange as it appears for most substance abusers, but not for the international tennis super-star Maria Sharapova who is now fighting a two-year doping ban: she’s decided to enroll in the Harvard Business School. Sharapova expressed her decision to attend Harvard through posts on Twitter and Facebook Saturday. The announcement comes as a reaction to the two-year suspension imposed by the International Tennis Federation due to a failed drug test at the 2016 Australian Open. Sharapova has always demonstrated remarkable business expertise outside the tennis court, and now is the time for her to formally show it to the world.
Not sure how this happened but Hey Harvard! Can't wait to start the program! 🎓📓 pic.twitter.com/EOoKYhaQli
— Maria Sharapova (@MariaSharapova) June 25, 2016
Sharapova has been found positive after a test for the banned substance meldonium during the Australian Open in January. Following this she has explained her stand at a press conference in March: she claimed that she has been taking the drug since 2006 as a remedy for health issues. Since the drug has been banned by WADA (World Anti-Doping Agency) in January, more than 200 athletes have tested positive for it.
However, the five-time grand slam champion has appealed to the Court of Arbitration for Sport (CAS) in June with the hope of reducing or completely eliminating the ban. If the ban is reduced and considered in effect since the day Sharapova tested positive, she is most likely to compete in the 2016 Olympics.
But, Sharapova is not going to waste her time expecting the court’s decision going in her favor. This is why she is going to take advantage of the program developed by the Harvard Business School for professional football players in 2005 to help them learn to evaluate business opportunities and manage their personal brand, among other skills.